The
GLP-1 drugs are accepted to deal with sort 2 diabetes and to assist folks drop pounds and hold it off.
NAION joins a growing list of side effects linked to GLP-1s, including a second eye warning to a number of labels.
The U.S. labels for Ozempic, Rybelsus, Trulicity, Mounjaro, and Zepbound already warn about diabetic retinopathy, a diabetes-related eye illness, in line with every drug’s prescribing info.
The 2 situations have an effect on totally different elements of the attention. Diabetic retinopathy damages tiny blood vessels within the retina, the layer in the back of the attention that senses gentle, in line with the
Mihail Zilbermint, MD, director of endocrine hospitalists at Johns Hopkins, informed Healthline he hasn’t seen NAION in his sufferers. He has seen imaginative and prescient worsen in some folks after they begin a GLP-1.
“However we imagine that’s in all probability associated to speedy enchancment of their sugar management, which can be seen in somebody who’s beginning insulin,” Zilbermint stated.
